FDA new step to support the evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are needed to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2TKHRsW
No comments:
Post a Comment